Citius Pharmaceuticals
Price & Volume
Stats
See moreOpen | $0.13 |
Previous Close | $0.16 |
Day Range | $0.11-$0.14 |
52W Range | $0.15-$1.07 |
Market Cap | $87.1M |
Shares Short | 11M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.24 |
News
See moreYahoo Finance • last year
Citius Pharmaceuticals Executes Definitive Agreement to Merge Wholly Owned Subsidiary with TenX Keane Acquisition to Form Publicly Listed Citius Oncology, Inc.
Yahoo Finance • last year
Citius Pharmaceuticals Announces Positive Results from the Phase 2b Study of Halo-Lido (CITI-002) for the Treatment of Hemorrhoids
Yahoo Finance • 2 years ago
Citius Pharmaceuticals Advances Mino-Lok® Phase 3 Trial Achieving 85 of 92 Events to Date
Yahoo Finance • 2 years ago
Sidoti's January Micro-Cap Conference
About
CEO | Mr. Leonard L. Mazur |
CFO | Mr. Jaime Bartushak |
Address | 11 Commerce Drive, Cranford, NJ, United States, 07016 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 22 |
